TY - JOUR T1 - Depressive symptomatology in adults during the COVID-19 pandemic JF - Journal of Investigative Medicine JO - J Investig Med SP - 436 LP - 445 DO - 10.1136/jim-2021-001992 VL - 70 IS - 2 AU - Álvaro Alexander Ocampo González AU - Javier Ferney Castillo García AU - Laura Carolina Pabón Sandoval AU - José Rafael Tovar Cuevas AU - Sirsa Aleyda Hidalgo Ibarra AU - Diego Alejandro Calle Sandoval AU - Edwin Cortés González AU - Kevin Steven Garcia Chica AU - Jonnathan Steven Pabón Lozano AU - María del Carmen Muñoz Rico Y1 - 2022/02/01 UR - http://hw-f5-jim.highwire.org/content/70/2/436.abstract N2 - Depression entails changes in the mental health of individuals worldwide. Episodes of depression lead to mood swings and changes in the motivational dimension. Our research focused on the prevalence of depression in the adult population and on how it affected the social and affective dimensions. Owing to the current pandemic, we deemed it necessary to explore how protective measures against COVID-19 infection, such as quarantines, could be related to mental health. Moreover, we found it important to determine the prevalence of depressive and anxious symptomatology in adults from the Valle del Cauca region in Colombia during the social isolation connected to COVID-19. Our study was descriptive, analytical and cross-sectional, and involved 1248 subjects. As tools, we used the Hamilton Depression Rating Scale and the Hamilton Anxiety Rating Scale. The data demonstrated that women were more likely to display symptoms of depression and that individuals aged between 24 and 29 were less likely to reveal symptoms of anxiety than those aged between 18 and 23. Moreover, childless or economically dependent individuals proved to be more likely to display symptoms of depression during the pandemic.All data relevant to the study are included in the article or uploaded as supplementary information. Data are not available as they are confidential. ER -